Robertet has launched a bioavailable, clean-label curcumin extract called curcuRouge.
Photo © Shutterstock.com/ COLOA Studio
Robertet (Grasse, France) has launched a bioavailable, clean-label curcumin extract called curcuRouge. The ingredient is part of a strategic partnership with bioavailability expert Tadashi Hashimoto, who developed curcuRouge. Hashimoto has developed 50 clinical studies on curcumin, 15 of which has been published. The patent-pending process used to create the extract is purportedly “clean,” using a non-controversial additive, making it a non-Novel Food ingredient. The increased bioavailability, solubility, and stability comes from the use of the non-crystalline form of curcumin, stabilized with a polymer matrix.
According to Robertet, research undergoing publication has shown 93 times greater absorption from curcuRouge, compared to a traditional extract. The ingredient’s solubility in water is 40% minimum, making it one of the highest concentrations of curcumin on the market, and allowing for use at low doses of 225-450 mg/day. CurcuRouge is therefore compatible with a number of applications in the nutraceutical, and functional food or beverage markets.
Roquette completes acquisition of IFF Pharma Solutions
May 1st 2025The integration of IFF Pharma Solution’s expertise and innovative product portfolio enhances Roquette’s “ability to deliver high-value drug delivery solutions to pharmaceutical customers worldwide while reinforcing its commitment to innovation,” according to the company’s press release.